Study reveals treatment gap for metastatic lung cancer patients, with only 48% receiving life-extending therapies despite advancements in treatment options. The analysis of 250,000 Medicare patients showed minimal improvement over 15 years, raising concerns about equitable access to care for the deadliest cancer in America.

Multiple barriers prevent patients from receiving treatment, including late diagnosis, shame among smokers, fatalism about the disease, and systemic inequities. Rural residents, unmarried patients, and Black and Hispanic individuals were significantly less likely to receive care, with one-third of patients never seeing an oncologist at all.

New targeted therapies and immunotherapies offer hope with fewer side effects than traditional chemotherapy, yet many patients still don't access these treatments. The disconnect between available medical advancements and actual patient outcomes represents a critical challenge in oncology care delivery.